Bronchopulmonary dysplasia: Pathogenesis and treatment
- PMID: 30542380
- PMCID: PMC6257511
- DOI: 10.3892/etm.2018.6780
Bronchopulmonary dysplasia: Pathogenesis and treatment
Abstract
Bronchopulmonary dysplasia (BPD) is a form of chronic lung disease of infancy, which mostly affects premature infants with significant morbidity and mortality. Premature infants who require to be treated for conditions including respiratory distress syndrome have a higher risk of developing BPD. In spite of the improvement in clinical methods, the incidence of BPD has not reduced. In the present review, the pathogenesis of BPD is described along with the treatments available at present and the role of nursing in the management of BPD. Emerging preventive therapies for BPD are also discussed, including the use of recombinant human superoxide dismutase, which has been proven effective in reducing respiratory injury and its long-term effects.
Keywords: bronchopulmonary dysplasia; hyperoxia; inflammation; preterm.
Similar articles
-
Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.Neonatology. 2015;107(4):358-9. doi: 10.1159/000381132. Epub 2015 Jun 5. Neonatology. 2015. PMID: 26044104 Review.
-
Recent Advances in Bronchopulmonary Dysplasia.Indian J Pediatr. 2021 Jul;88(7):690-695. doi: 10.1007/s12098-021-03766-w. Epub 2021 May 20. Indian J Pediatr. 2021. PMID: 34018135 Review.
-
Clinical characteristics of bronchopulmonary dysplasia in very preterm infants.Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 Oct 28;48(10):1592-1601. doi: 10.11817/j.issn.1672-7347.2023.230192. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023. PMID: 38432888 Free PMC article. Chinese, English.
-
Insulin-like growth factor-1 replacement therapy after extremely premature birth: An opportunity to optimize lifelong lung health by preserving the natural sequence of lung development.Paediatr Respir Rev. 2023 Dec;48:24-29. doi: 10.1016/j.prrv.2023.05.001. Epub 2023 May 6. Paediatr Respir Rev. 2023. PMID: 37268507 Review.
-
Stem-Cell Therapy for Bronchopulmonary Dysplasia (BPD) in Newborns.Cells. 2022 Apr 9;11(8):1275. doi: 10.3390/cells11081275. Cells. 2022. PMID: 35455954 Free PMC article. Review.
Cited by
-
Intrauterine Hypoxia and Epigenetic Programming in Lung Development and Disease.Biomedicines. 2021 Aug 2;9(8):944. doi: 10.3390/biomedicines9080944. Biomedicines. 2021. PMID: 34440150 Free PMC article. Review.
-
Pathogenesis of bronchopulmonary dysplasia in preterm neonates revealed by an RNA sequencing interaction network analysis.Transl Pediatr. 2022 Dec;11(12):2004-2015. doi: 10.21037/tp-22-590. Transl Pediatr. 2022. PMID: 36643677 Free PMC article.
-
Inhibition of microRNA-29a alleviates hyperoxia-induced bronchopulmonary dysplasia in neonatal mice via upregulation of GAB1.Mol Med. 2019 Dec 31;26(1):3. doi: 10.1186/s10020-019-0127-9. Mol Med. 2019. PMID: 31892308 Free PMC article.
-
L-citrulline attenuates lipopolysaccharide-induced inflammatory lung injury in neonatal rats.Pediatr Res. 2023 Nov;94(5):1684-1695. doi: 10.1038/s41390-023-02684-1. Epub 2023 Jun 22. Pediatr Res. 2023. PMID: 37349511
-
Risk prediction of bronchopulmonary dysplasia in preterm infants by the nomogram model.Front Pediatr. 2023 Mar 14;11:1117142. doi: 10.3389/fped.2023.1117142. eCollection 2023. Front Pediatr. 2023. PMID: 36999082 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources